Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer
HER2 癌基因放射杂交成像检测乳腺癌
基本信息
- 批准号:7536308
- 负责人:
- 金额:$ 11.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-02 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:All SitesAnimal ExperimentsAnimal ModelBase SequenceBenignBiopsyBloodBreastBreast Cancer CellCCND1 geneCancer EtiologyCellsCessation of lifeChelating AgentsContralateralCytoplasmDetectionDiagnosisDiffuseDiscipline of Nuclear MedicineDoxorubicinERBB2 geneEffectivenessEpidermal Growth Factor ReceptorEstrogen AntagonistsEstrogen Receptor ModulatorsEstrogen ReceptorsEstrogensFigs - dietaryFutureGeneticHumanIGF1 geneIGF1R geneIRS1 geneImageInjection of therapeutic agentInsulin-Like Growth Factor IInvasiveKRAS2 geneKidneyLesionLifeLiverMCF7 cellMalignant - descriptorMalignant neoplasm of pancreasMalignant neoplasm of prostateMammographyMeasurementMeasuresMessenger RNAMetabolicMonitorMusMuscleNucleic Acid ProbesNucleic acid sequencingOncogenesOrganOther Agency or OrganizationPeptide Nucleic AcidsPeptidesPhasePhotonsPositronPositron-Emission TomographyProceduresProgesterone ReceptorsProteinsPublic HealthRNARadioisotopesRangeRelative (related person)ReporterScanningSignal TransductionSiteSlideStaining methodStainsTP53 geneTailTamoxifenTestingTimeTissuesTransgenic MiceTransgenic OrganismsVeinsWeekWomanXenograft procedureanalogbasecancer cellchemotherapycostdesignimaging probeinsulin receptor substrate 1 proteinmalignant breast neoplasmmolecular imagingnew technologypeptide analogreceptorresponsetumoruptake
项目摘要
DESCRIPTION (provided by applicant): Aggressive, invasive breast cancer will attack >180,000 women in the US in 2007, and will take the lives of >40,000 women. Mammograms detect lumps in breasts, H80% of which are benign, and H20% are malignant. Lumps are biopsied to determine whether they are benign or malignant. But biopsies do not determine which oncogenes are activated, and do not reliably diagnose estrogen-dependent vs. estrogen-independent breast cancer. The cells in malignant lumps divide frequently due to mutational activation of cancer genes. We have designed and demonstrated a novel technology to see visualize hyperactive cancer genes from outside the body, which we call radiohybridization imaging (RHI). RHI scans the entire breast to find all sites of cancer gene activation, whether or not a lump has formed. RHI probes are peptide nucleic acid (PNA) sequences that hybridize specifically to messenger RNAs (mRNAs) copied from activated cancer genes. We added a small peptide analog to allow the RHI probes to be taken up by the breast cancer cells. Finally, we chelated radionuclides to permit external imaging by positron emission tomography (PET) scanning. RHI probes for CCND1, IRS1, MYCC, and KRAS mRNAs, injected into animal models, enabled us to visualize breast cancer, pancreas cancer, and prostate cancer xenografts. High levels of human epidermal growth factor receptor 2 (Her2) protein are associated with aggressive, invasive, estrogen-independent breast cancers. Measurements of HER2 mRNA demonstrated that Her2+ breast cancer cells express thousands of HER2 mRNAs per cell, while Her2- breast cancer cells express much less. We hypothesize that external radiohybridization imaging of HER2 oncogene expression will detect aggressive Her2+ breast cancers noninvasively, enabling faster, more accurate, more cost-effective diagnosis. Phase 1: Milestone 1: We will synthesize and purify a HER2 mRNA RHI agent and mismatch controls to e95% purity. Milestone 2: We will determine whether or not the HER2 mRNA RHI agent will show e3-fold greater accumulation in human Her2+ breast cancer cells in culture, vs. mismatch controls. Phase 2: Milestone 1: We will optimize the sensitivity of the HER2 mRNA RHI agent, vs. mismatch controls, in human Her2+ and Her2- breast cancer xenografts by varying the specific activity over a wide range, in order to achieve e3-fold greater PET image contrast in the xenografts, relative to normal contralateral tissue. Milestone 2: We will determine which agent, among macrocyclic chelators, oligolysines, and IGF1 analogs, will reduce nonspecific organ uptake by e2-fold. Milestone 3: We will determine whether radiohybridization imaging of HER2 mRNA following chemotherapy in Her2+ transgenic mice that develop spontaneous breast cancers will show e2-fold decrease in PET image contrast in the tumor, relative to normal contralateral tissue, vs. Her2- control mice, as a response to chemotherapeutic interdiction of proliferation. RHI measurement of HER2 mRNA levels will be compared with FDG measurement of metabolic activity over time. PUBLIC HEALTH RELEVANCE: We propose to develop a genetic nuclear medicine procedure to detect hyperactive breast cancer genes from outside the body. We intend to identify developing breast cancers before they form a tumor. In animal models, we will test for the possibility of breast cancer gene signals from tissues that are really benign, and for lack of breast cancer gene signals from tissues that are really malignant. In the future, imaging multiple breast cancer genes might diagnose estrogen-dependent vs. estrogen-independent breast cancer without an invasive procedure.
描述(申请人提供):侵袭性、浸润性乳腺癌将在2007年侵袭美国18万名妇女,夺走40,000名妇女的生命。乳房X光检查发现乳房内有肿块,其中80%是良性的,20%是恶性的。对肿块进行活检以确定它们是良性的还是恶性的。但活组织检查不能确定哪些癌基因被激活,也不能可靠地诊断雌激素依赖型乳腺癌和非雌激素依赖型乳腺癌。由于癌症基因的突变激活,恶性肿块中的细胞经常分裂。我们设计并演示了一种新技术,可以从体外观察高度活跃的癌症基因,我们称之为放射杂交成像(RHI)。RHI扫描整个乳房,寻找癌症基因激活的所有位置,无论是否形成肿块。RHI探针是与从激活的癌症基因复制的信使RNA(MRNAs)特异杂交的多肽核酸(PNA)序列。我们添加了一种小肽类似物,使RHI探针能够被乳腺癌细胞摄取。最后,我们将放射性核素进行螯合,通过正电子发射断层扫描(PET)进行外部成像。将针对CCND1、IRS1、MYCC和KRAS mRNAs的RHI探针注入动物模型,使我们能够可视化乳腺癌、胰腺癌和前列腺癌的异种移植。高水平的人类表皮生长因子受体2(Her2)蛋白与侵袭性、侵袭性、雌激素非依赖性乳腺癌有关。HER2信使核糖核酸的测定表明,Her2+乳腺癌细胞每个细胞表达数千个HER2mRNAs,而Her2-乳腺癌细胞表达的HER2mRNAs要少得多。我们假设,HER2癌基因表达的体外放射杂交成像将无创性地检测到侵袭性Her2+乳腺癌,从而能够更快、更准确、更具成本效益地诊断。阶段1:里程碑1:我们将合成和纯化HER2 mRNA RHI试剂和错配对照,使其纯度达到E95%。里程碑2:我们将确定HER2mRNA RHI试剂在培养的人Her2+乳腺癌细胞中是否会显示E3倍的积累,而不是错配对照。阶段2:里程碑1:我们将通过在很大范围内改变HER2+和Her2-乳腺癌移植瘤的比活性来优化HER2 mRNA RHI试剂与错配对照的敏感性,以便在移植瘤中实现比正常对侧组织高E3倍的PET图像对比度。里程碑2:我们将确定在大环络合剂、寡聚酶和IGF1类似物中,哪种药物可以将非特异性器官摄取减少e2倍。里程碑3:我们将确定在发生自发性乳腺癌的Her2+转基因小鼠中,化疗后HER2 mRNA的放射杂交成像是否会显示肿瘤中的PET图像对比度比正常对侧组织减少e2倍,作为对化疗抑制增殖的反应。HER2mRNA水平的RHI测量将与FDG的代谢活性测量进行比较。公共卫生相关性:我们建议开发一种基因核医学程序,从体外检测过度活跃的乳腺癌基因。我们打算在形成肿瘤之前识别出正在发展中的乳腺癌。在动物模型中,我们将测试来自真正良性组织的乳腺癌基因信号的可能性,以及来自真正恶性组织的乳腺癌基因信号缺失的可能性。在未来,对多个乳腺癌基因进行成像可能会诊断雌激素依赖型乳腺癌和非雌激素依赖型乳腺癌,而不需要进行侵入性手术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian David Gray其他文献
Brian David Gray的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian David Gray', 18)}}的其他基金
Phosphatidylserine-blocking nanoparticles as improved anti-thrombotic with reduced bleeding risk
磷脂酰丝氨酸阻断纳米颗粒可改善抗血栓形成并降低出血风险
- 批准号:
10598788 - 财政年份:2023
- 资助金额:
$ 11.58万 - 项目类别:
Instantaneous Tumor Spray for Real-Time Surgical Guidance
用于实时手术指导的瞬时肿瘤喷雾
- 批准号:
10681383 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
Instantaneous Tumor Spray for Real-Time Surgical Guidance
用于实时手术指导的瞬时肿瘤喷雾
- 批准号:
10543617 - 财政年份:2022
- 资助金额:
$ 11.58万 - 项目类别:
Topical Drug Treatment of Cutaneous Leishmaniasis
皮肤利什曼病的局部药物治疗
- 批准号:
9383791 - 财政年份:2017
- 资助金额:
$ 11.58万 - 项目类别:
Multicolor Cell Membrane Profiling For Development And Disease
发育和疾病的多色细胞膜分析
- 批准号:
8589954 - 财政年份:2013
- 资助金额:
$ 11.58万 - 项目类别:
Anionic Phospholipid-Selective PET/SPECT Agent for Infection Imaging
用于感染成像的阴离子磷脂选择性 PET/SPECT 试剂
- 批准号:
8250164 - 财政年份:2012
- 资助金额:
$ 11.58万 - 项目类别:
Dual Modality Labels for Macro and Micro Detection and Quantification of Stem Cel
用于干细胞宏观和微观检测及定量的双模态标签
- 批准号:
7909750 - 财政年份:2010
- 资助金额:
$ 11.58万 - 项目类别:
Radiohybridization Imaging of HER2 Oncogene to Detect Breast Cancer
HER2 癌基因放射杂交成像检测乳腺癌
- 批准号:
7681555 - 财政年份:2008
- 资助金额:
$ 11.58万 - 项目类别:
Optimizing Tracers For Multicolor Neuronal Profiling
优化多色神经元分析示踪剂
- 批准号:
7418498 - 财政年份:2004
- 资助金额:
$ 11.58万 - 项目类别:
相似海外基金
Development of decellularized small-diameter arterial grafts and evaluation in large animal experiments
脱细胞小直径动脉移植物的研制及大动物实验评价
- 批准号:
21H03016 - 财政年份:2021
- 资助金额:
$ 11.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
- 批准号:
NC/R001707/1 - 财政年份:2018
- 资助金额:
$ 11.58万 - 项目类别:
Training Grant
Developing and validating a computational model of the gut microbiota-mucosa interactions to replace and reduce animal experiments
开发和验证肠道微生物群-粘膜相互作用的计算模型,以取代和减少动物实验
- 批准号:
2103295 - 财政年份:2018
- 资助金额:
$ 11.58万 - 项目类别:
Studentship
Research on the way of information transmission to gain social understanding of animal experiments
动物实验获得社会理解的信息传递方式研究
- 批准号:
16K07080 - 财政年份:2016
- 资助金额:
$ 11.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CDS&E: Modeling the Zebrafish Model Organism Toward Reducing, Refining, and Replacing Animal Experiments
CDS
- 批准号:
1505832 - 财政年份:2015
- 资助金额:
$ 11.58万 - 项目类别:
Standard Grant
Never replicate a successful experiment? Standardization, heterogenization and reproducibility in animal experiments
从未复制过成功的实验?
- 批准号:
283089959 - 财政年份:2015
- 资助金额:
$ 11.58万 - 项目类别:
Research Grants
Arrhythmogenic Drug Evaluation System by Simplified Animal Experiments
简化动物实验的致心律失常药物评价系统
- 批准号:
26350520 - 财政年份:2014
- 资助金额:
$ 11.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promotion of the 4Rs in animal experiments by the development of a production process for polyclonal antibodies using a goldfish
开发金鱼多克隆抗体生产工艺,促进动物实验中的4R
- 批准号:
23650227 - 财政年份:2011
- 资助金额:
$ 11.58万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of microangiographic systems to visualize cerebular perforating artery in clinical settings and retrobulbar ophthalmic artery arteries in animal experiments.
开发显微血管造影系统,以在临床环境中可视化小脑穿支动脉,并在动物实验中可视化球后眼动脉。
- 批准号:
23390305 - 财政年份:2011
- 资助金额:
$ 11.58万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The study for the modification of cerebral synapses by balance exercises in the elderly based on animal experiments.
基于动物实验的老年人平衡运动改变大脑突触的研究。
- 批准号:
21500471 - 财政年份:2009
- 资助金额:
$ 11.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)